UnitedHealth Group Incorporated (UNH) — closed signal from November 22, 2025
Partial Published before the outcome was known, scored automatically when the window closed on February 20, 2026.
Predicted vs. what happened
What happened
Reached 60% of the predicted growth at its peak, without hitting the target.
The thesis — published November 22, 2025
UnitedHealth is a large, well-known health company that has been under pressure because of regulatory talk and how its services are being used. Price action is mixed and a bit below its recent average, but investor feeling is very positive, which suggests big investors are adding slowly. With no fresh news, expect a cautious recovery over the next few months if policy uncertainty eases.
Primary drivers
- Large, diversified health and insurance business with scale advantages.
- Stock is settling after a pullback and shows signs of steady buying.
- Investor sentiment is very strong despite weak near-term fundamentals.
- Future policy and how services are used will swing performance.
How it played out
UNH: thesis partially played out, target not reached
Lyra published UNH at $317.83 on 2025-11-22, with expected growth of 21%. The thesis pointed to UnitedHealth's scale, a stock settling after a pullback, signs of steady buying, very strong investor sentiment, and policy uncertainty as a key swing factor.
Inside the window, UNH rose to a peak of $357.87 on 2026-01-23, a 12.6% gain. It stayed below the $382.01 target and never reached it. By 2026-02-20, it ended at $290. The thesis partly played out early, but the full target missed.
What happened during the window
On January 27, 2026, MarketWatch reported that UnitedHealth said it expected 2026 revenue to decline, with guidance above $439 billion. The same report said the company reported fourth-quarter revenue of $113.2 billion and a drop in fourth-quarter net earnings.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.